Etibendazole

This classification denotes an antihelminthic agent with the molecular formula C18H16FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1XU086MM3H, chemically known as r 34,803 but generally known as etibendazole, which bears US NIH Compound Identifier 71745. European Medicines Agency schedules Etibendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07295MIG. The term ETIBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). ETIBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etibendazole under HS 29349990 and SITC 51579. As of Q4 2014, ETIBENDAZOLE remains the US FDA Preferred Term for this commodity. Etibendazole bears US NLM identifiers UMLS ID C1880578 and NCI Concept Code C65571. SMILES: FC1CCC(C2(OCCO2)C2CC3[NH]C(NC3CC2)NC(=O)OC)CC1.